Drugs / Tritanrix-HepB/Hib
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00348881 Comparator | Jun 2006 → Oct 2007 | diphtheria, hepatitis B virus infection, influenza, pertussis +1 | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tritanrix HepB/Hib | “Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants” NCT00348881 ↗ |
| Modality | Vaccine | “Tritanrix-HepB/Hib™ vaccine” NCT00348881 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT00348881 ↗ |